Harding Loevner LP Bio N Tech Se Transaction History
Harding Loevner LP
- $17.6 Billion
- Q2 2024
A detailed history of Harding Loevner LP transactions in Bio N Tech Se stock. As of the latest transaction made, Harding Loevner LP holds 2,926,761 shares of BNTX stock, worth $351 Million. This represents 1.34% of its overall portfolio holdings.
Number of Shares
2,926,761
Previous 3,818,163
23.35%
Holding current value
$351 Million
Previous $352 Million
33.23%
% of portfolio
1.34%
Previous 2.24%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$992 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$574 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$525 Million1.49% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$217 Million0.68% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...